Heavy Medicine Holdings: As of the end of October, a total of 80.9988 million yuan has been spent on repurchasing shares.

Repharm Holdings announced that the company passed a proposal to repurchase shares in July 2025, with a total funding amount of 80-100 million yuan. The repurchase price will not exceed 6.6 yuan per share, with a term of 12 months. As of October 31, the company has repurchased a cumulative total of 15.4066 million shares, accounting for 0.8915% of the total share capital, with a highest transaction price of 5.48 yuan per share, and a lowest of 5.01 yuan per share, totaling 80.9988 million yuan. The company will continue to implement the repurchase according to the plan and disclose information in a timely manner.